» Articles » PMID: 27033597

Aldose Reductase Mediates Retinal Microglia Activation

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2016 Apr 2
PMID 27033597
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Retinal microglia (RMG) are one of the major immune cells in charge of surveillance of inflammatory responses in the eye. In the absence of an inflammatory stimulus, RMG reside predominately in the ganglion layer and inner or outer plexiform layers. However, under stress RMG become activated and migrate into the inner nuclear layer (INL) or outer nuclear layer (ONL). Activated RMG in cell culture secrete pro-inflammatory cytokines in a manner sensitive to downregulation by aldose reductase inhibitors. In this study, we utilized CX3CR1(GFP) mice carrying AR mutant alleles to evaluate the role of AR on RMG activation and migration in vivo. When tested on an AR(WT) background, IP injection of LPS induced RMG activation and migration into the INL and ONL. However, this phenomenon was largely prevented by AR inhibitors or in AR null mice, or was exacerbated in transgenic mice that over-express AR. LPS-induced increases in ocular levels of TNF-α and CX3CL-1 in WT mice were substantially lower in AR null mice or were reduced by AR inhibitor treatment. These studies demonstrate that AR expression in RMG may contribute to the proinflammatory phenotypes common to various eye diseases such as uveitis and diabetic retinopathy.

Citing Articles

Do microglia metabolize fructose in Alzheimer's disease?.

Sturno A, Hassell Jr J, Lanaspa M, Bruce K J Neuroinflammation. 2025; 22(1):85.

PMID: 40089786 DOI: 10.1186/s12974-025-03401-x.


Methylglyoxal Formation-Metabolic Routes and Consequences.

Vaskova J, Kovacova G, Pudelsky J, Palencar D, Mickova H Antioxidants (Basel). 2025; 14(2).

PMID: 40002398 PMC: 11852113. DOI: 10.3390/antiox14020212.


Aldose reductase is a potential therapeutic target for neurodegeneration.

Rao M, Chang K Chem Biol Interact. 2024; 389:110856.

PMID: 38185272 PMC: 10842418. DOI: 10.1016/j.cbi.2024.110856.


Macrophage/microglia polarization for the treatment of diabetic retinopathy.

Yao Y, Li J, Zhou Y, Wang S, Zhang Z, Jiang Q Front Endocrinol (Lausanne). 2023; 14:1276225.

PMID: 37842315 PMC: 10569308. DOI: 10.3389/fendo.2023.1276225.


Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.

Padovani-Claudio D, Ramos C, Capozzi M, Penn J Prog Retin Eye Res. 2023; 94:101151.

PMID: 37028118 PMC: 10683564. DOI: 10.1016/j.preteyeres.2022.101151.


References
1.
Obrosova I, Kador P . Aldose reductase / polyol inhibitors for diabetic retinopathy. Curr Pharm Biotechnol. 2010; 12(3):373-85. DOI: 10.2174/138920111794480642. View

2.
Kettenmann H, Hanisch U, Noda M, Verkhratsky A . Physiology of microglia. Physiol Rev. 2011; 91(2):461-553. DOI: 10.1152/physrev.00011.2010. View

3.
Seo M, Kwak N, Ozaki H, Yamada H, Okamoto N, Yamada E . Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol. 1999; 154(6):1743-53. PMC: 1866636. DOI: 10.1016/S0002-9440(10)65430-2. View

4.
Alliot F, Godin I, Pessac B . Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res. 1999; 117(2):145-52. DOI: 10.1016/s0165-3806(99)00113-3. View

5.
Chen L, Mu Y, Greene W . Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 2002; 21(23):6539-48. PMC: 136963. DOI: 10.1093/emboj/cdf660. View